Table 1.
Citation | Type of particle# | Particle coating |
Size (nm)## | Con- centration### |
Type of sample | Application | ||
---|---|---|---|---|---|---|---|---|
Magnetic Nanoparticles | OCT | Oh, 2008 [64] | MIO, bead | Dextran | 5 (core), 40 (OD) | 0.2 mM Fe/kg | ex vivo rabbit tissue | atherosclerosis |
Oldenburg, 2010 [74] | Feridex™, cluster | Dextran | 5 (core)**, 36-100 (OD) | 70 μg/mL | ex vivo porcine artery | thrombosis | ||
Oldenburg, 2012 [75] | MIO, bead | Dextran | 10-20 (core), 20-30 (OD) | 41-43 μg/mL | ex vivo blood clots | thrombosis | ||
Oh, 2007 [63] | Feridex™, cluster | Dextran | 5 (core)**, 36-100 (OD) | 1.5 mM Fe/kg | ex vivo liver, spleen | macrophages | ||
Oldenburg, 2005 [4] | Fe3O4, bead | (none) | 20-30 (core) | NA | in vivo tadpole | optical biopsy | ||
John, 2010 [79] | MIO, bead | Antibody, dextran |
20-30 (core) | NA | in vivo rat tumor | breast cancer | ||
Oldenburg, 2008 [81] | Fe3O4, bead | (none) | 20-30 (core) | 2 nM* | phantom | tumor imaging | ||
MIO, sphere | COOH | 20 (core), 22 (OD) | NA | ex vivo rat tumor | ||||
John, 2012 [82] |
Ferrofluid/dye-filled protein sphere |
Peptide | 20-30 (core)**, 2000-5000 (OD) |
1 × 1011/mL | ex vivo rat tumor | cancer | ||
Kim, 2013 [30] |
Ferrofluid/dye-filled protein sphere |
Peptide | 20-30 (core)**, 2000-5000 (OD) |
.001pM | liquid phantom | intravascular | ||
Wang, 2010 [88] | MIO, bead | Streptavidin | 1000 (core) | <4 mg/mL | in vivo mouse eye | anterior eye | ||
in vitro mouse eye | ||||||||
Kim, 2014 [83] |
Ferrofluid/dye-filled protein sphere |
Peptide | 20-30 (core)**, 2000-5000 (OD) |
4.48 pM | ex vivo porcine artery | atherosclerosis | ||
Huang, 2015 [25] | Fe3O4, cluster | NA | NA | <150 ppm | cell culture | cancer | ||
Oldenburg, 2005 [60] | Fe3O4, powder | (none) | 1920 (core) | <1.2 mg/mL | cell culture | cell labeling | ||
OCE | Crecea, 2009 | Fe3O4, bead | (none) | 25 (core) | 2.5 mg/mL | phantom | rheology | |
Crecea, 2013 [70] | Fe3O4, bead | (none) | 25 (core) | NA | ex vivo rabbit tissue | microrheology | ||
Ahmad, 2014 [29] | Fe3O4, bead | (none) | 50-100 (core) | 250 mg/mL | phantom | elastography | ||
<250 mg/mL | ex vivo rat liver | |||||||
<250 mg/mL | ex vivo chicken muscle | |||||||
OCM | Crecea, 2014 [71] |
Ferrofluid-filled protein sphere |
NA | 900-3500 (OD) | NA | 3D mammary cell culture | cellular mechanics | |
MIO, bead | PS & dye | 1000-2000 (OD) | ||||||
ODT | Kim, 2007 | Feridex™ | Dextran | 5 (core)**, 36-100 (OD) | 360 μg Fe / mL* | capillary tube | fluid flow | |
Plasmonic Nanoparticles | DOCT | Lee, 2011 | Gold, ring | PEG | 179 (OD), 149 (ID), 97(h) | <40 pM | ex vivo mouse liver | drug delivery |
Chhetri, 2011[57] | Gold, rod | CTAB | 53 (L), 15 (d) | 1320 pM | viscous fluids | viscometry | ||
Chhetri, 2014[58] | Gold, rod | PEG | 83 (L), 22 (d) | 112 pM* | 3D airway & breast culture | tissue nanotopology | ||
Oldenburg, 2013[124] | Gold, rod | PEG | 83 (L), 22 (d) | <547 pM | 3D tumor organoids | molecular imaging | ||
PTOCT | Chi, 2014[119] | Gold, ring | NA | 155 (OD), 130 (ID), 50 (h) | <3.32 pM | ex vivo pig liver | molecular imaging | |
Tucker, 2015[54] | Gold, rod | PEG | 45.2 (L),13.2 (d) | <200 pM | in vivo mouse ear | molecular imaging | ||
Xiao, 2013[118] | Gold, smart rose | C5H7NO3 | 10 (d)** | <60 nM | cell culture | cancer | ||
Paranjape, 2010[117] | Gold, rose | dextran | ~30 (d) | 0.531 pM* | phantom | macrophages | ||
NA | ex vivo aorta | |||||||
Adler, 2008[51] | Gold, shell | NA | 136 (OD), 120 (ID) | <16.6 pM | GNP solution | molecular imaging | ||
Nahas, 2014[120] | Gold, shell | PEG | 150 (OD), 130 (ID) | <4.15 pM | ex vivo mouse skin | phototherapy | ||
Zhou, 2010[116] | Gold, shell | NA | 152 (OD), 120 (ID) | <8.30 pM | ex vivo breast tissue | molecular imaging | ||
Skala, 2008[52] | Gold, sphere | PEG | 60 (d) | 26 pM* | liquid phantom | molecular imaging | ||
<39 pM | cell culture | |||||||
SOCT | Cang, 2005[40] | Gold, cage | NA | 35 (L,w,h) | <500 pM | phantom | molecular imaging | |
Wei, 2009[97] | Gold, rod | CTAB | NA | 2 pM | phantom | molecular imaging | ||
Oldenburg, 2009[114] | Gold, rod | CTAB | 45 (L), 15 (d) | <10-20 nM | ex vivo breast tissue | breast cancer | ||
Jia, 2015[98] | Gold, rod | PEG-Tat | 50-59 (L), 10 (d) | <83 pM | cell culture | retina | ||
Rawashdeh, 2015[115] | Gold, rod | CTAB | 75 (L), 20 (d) | <912 nM | ex vivo chicken | blood vessels |
magnetic iron oxide (MIO)
indicated by core, outer diameter (OD) inner diameter (ID), length (L), width (w), diameter (d), or height (h)
by mass density (w/v); particle density (v−1), particle molarity (pM-nM), or dose (molarity Fe/w)
minimum concentration needed for detection
particle size within cluster or fluid